14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 60 days ( 0 % )
Last Price $0.88 0 %
High/ Low $0.88 - $0.88 0%
Chg 7 Days N/A $0.88 $0.88
Chg 30 Days N/A $0.88 $0.88
Chg 12 mos -52.37 % $1.85 $0.88
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -35.78 % Width: 96.85 %
Pred. range - 3 mos $0.88 - $0.88 0 % - 0 %
Pred. range - 12 mos $0.355 - $0.699 -59.73 % - -20.72 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Nov 03, 2023 - 68 days
Long MA avg 12 mos Sell Nov 03, 2023 - 68 days
Short/Long MA avg 12 mos Sell Nov 14, 2023 - 61 days
Pivot Short Buy Feb 09, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Selecta Biosciences Inc

Selecta Biosciences Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the t... SELB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT